HomeAI · summaries
Storia in 15 fonti
Moderna stock drops 12% after 177% surge: Here’s what Wall Street says about MRNA
Moderna stock falls 12% after a 177% surge as investors weigh the intismeran cancer vaccine win, future demand, pricing and other cancer trials. | Business News
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
- ·
expansion.com
Moderna se dispara m�s del 140% en Bolsa al anunciar resultados positivos en un ensayo cl�nico
Las acciones de las norteamericanas Moderna y Merck (conocida fuera de Estados Unidos y Canad� como MSD) se dispararon este mi�rcoles durante su negociaci�n en el mercado...
